New Perceptions

Dr. Albert Garcia-Romeu obtained his Ph.D. in Psychology from the Institute of Transpersonal Psychology in 2012 for his research on self-transcendence and meditation. He completed his post-doc in Behavioral Pharmacology. He currently is an Assistant Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine and is a guest researcher at the National Institute for Drug Abuse Intramural Neuroimaging Research Branch.

Dr. Garcia-Romeu's Publications

Online Study of Naturalisti Psilocybin Use

Referenced Articles:

Psychiatry & the psychedelic drugs. Past, present & future -Dr. James Rucker

Human hallucinogen research: guidelines for safety -Dr. Matt Johnson

Follow us:

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/

If you like what you heard in this episode please consider supporting us:

https://anchor.fm/journalofpsychedelic/support

Dr. Albert Garcia-Romeu obtained his Ph.D. in Psychology from the Institute of Transpersonal Psychology in 2012 for his research on self-transcendence and meditation. He completed his post-doc in Behavioral Pharmacology. He currently is an Assistant Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine and is a guest researcher at the National Institute for Drug Abuse Intramural Neuroimaging Research Branch.

Dr. Garcia-Romeu's Publications

Online Study of Naturalisti Psilocybin Use

Referenced Articles:

Psychiatry & the psychedelic drugs. Past, present & future -Dr. James Rucker

Human hallucinogen research: guidelines for safety -Dr. Matt Johnson

Follow us:

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/

If you like what you heard in this episode please consider supporting us:

https://anchor.fm/journalofpsychedelic/support

Join Editor-in-Chief Dr. Tyler Kjorvestad of The Journal of Psychedelic Psychiatry as he discusses the article Holotropic Breathwork: A Review found in the latest issue, with the author Dr. John Jacob.

Stanislav Grof Holotropic Breathwork: A New Approach to Self-Exploration and Therapy

Follow us:

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/

Join Editor-in-Chief Dr. Tyler Kjorvestad of The Journal of Psychedelic Psychiatry as he discusses the article Holotropic Breathwork: A Review found in the latest issue, with the author Dr. John Jacob.

Stanislav Grof Holotropic Breathwork: A New Approach to Self-Exploration and Therapy

Follow us:

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/

Dr. Thomas Roberts obtained his Master from the University of Connecticut and completed his Ph.D. in Psychology at Stanford University. He is an Emeritus Professor of Psychology at Northern Illinois University and was a founding member of the Multidisciplinary Association for Psychedelic Studies or MAPS.

Follow us:

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/

Sponsor: https://anchor.fm/

Dr. Roberts' Books:

Psychedelic Horizons

Mindapps: Multistate Theory and Tools for Mind Design

The Psychedelic Policy Quagmire: Health, Law, Freedom, and Society (Psychology, Religion, and Spirituality)

Referenced Material:

Bicycle Day Graphic Novel

Realms of the Human Unconscious: Observations from LSD Research

The Psychedelic Explorer's Guide: Safe, Therapeutic, and Sacred Journeys

MAPS

Heffter Research Institue

The Psychedelic Renaissance: Reassessing the Role of Psychedelic Drugs in 21st Century Psychiatry and Society

Seeking the Sacred with Psychoactive Substances [2 volumes]: Chemical Paths to Spirituality and to God (Psychology, Religion, and Spirituality)

Dr. Thomas Roberts obtained his Master from the University of Connecticut and completed his Ph.D. in Psychology at Stanford University. He is an Emeritus Professor of Psychology at Northern Illinois University and was a founding member of the Multidisciplinary Association for Psychedelic Studies or MAPS.

Follow us:

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/

Sponsor: https://anchor.fm/

Dr. Roberts' Books:

Psychedelic Horizons

Mindapps: Multistate Theory and Tools for Mind Design

The Psychedelic Policy Quagmire: Health, Law, Freedom, and Society (Psychology, Religion, and Spirituality)

Referenced Material:

Bicycle Day Graphic Novel

Realms of the Human Unconscious: Observations from LSD Research

The Psychedelic Explorer's Guide: Safe, Therapeutic, and Sacred Journeys

MAPS

Heffter Research Institue

The Psychedelic Renaissance: Reassessing the Role of Psychedelic Drugs in 21st Century Psychiatry and Society

Seeking the Sacred with Psychoactive Substances [2 volumes]: Chemical Paths to Spirituality and to God (Psychology, Religion, and Spirituality)

Join Editor-in-Chief Dr. Tyler Kjorvestad of The Journal of Psychedelic Psychiatry as he reviews the article The Psychiatric Utility of MDMA by Dr. Mark Sundahl found in the latest issue.

Follow us:

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/

Sponsor: https://anchor.fm/

Join Editor-in-Chief Dr. Tyler Kjorvestad of The Journal of Psychedelic Psychiatry as he reviews the article The Psychiatric Utility of MDMA by Dr. Mark Sundahl found in the latest issue.

Follow us:

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/

Sponsor: https://anchor.fm/

Join Editor-in-Chief Dr. Tyler Kjorvestad of The Journal of Psychedelic Psychiatry as he discusses the article Life after attempted death: A case report of symptom mitigation with the use of LSD in methamphetamine use disorder and other psychiatric comorbidities found in the latest issue, with the author Dr. JP Martell.

AJP Article on Ketamine as a treatment for Cocaine Use Disorder:

https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2019.18101123

Follow us:

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/

Join Editor-in-Chief Dr. Tyler Kjorvestad of The Journal of Psychedelic Psychiatry as he discusses the article Life after attempted death: A case report of symptom mitigation with the use of LSD in methamphetamine use disorder and other psychiatric comorbidities found in the latest issue, with the author Dr. JP Martell.

AJP Article on Ketamine as a treatment for Cocaine Use Disorder:

https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2019.18101123

Follow us:

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/

Join the Editors of The Journal of Psychedelic Psychiatry as they discuss the MDMA, Psilocybin, and Ayahuasca with Special Guest and Psychiatrist Dr. Charles Grob.

Dr. Charles Grob obtained his M.D. from State University of New York and completed residency in Psychiatry. He currently serves as an Investigator for The Lunquist Institute, Professor of Psychiatry and Biobehavioral Sciences and Pediatrics at UCLA SOM, and is the Director of the Child and Adolescent Psychiatry Division at Harbor-UCLA Medical Center. He can also be seen in Netflix’s film Have a Good Trip which is currently available

Referenced Works on Psychedelics:

Ralph Metzner

Higher Wisdom

Storming Heaven

Acid Dreams

The Harvard Psychedelic Club

Changing Our Mind

Distilled Spirits

Join the Editors of The Journal of Psychedelic Psychiatry as they discuss the MDMA, Psilocybin, and Ayahuasca with Special Guest and Psychiatrist Dr. Charles Grob.

Dr. Charles Grob obtained his M.D. from State University of New York and completed residency in Psychiatry. He currently serves as an Investigator for The Lunquist Institute, Professor of Psychiatry and Biobehavioral Sciences and Pediatrics at UCLA SOM, and is the Director of the Child and Adolescent Psychiatry Division at Harbor-UCLA Medical Center. He can also be seen in Netflix’s film Have a Good Trip which is currently available

Referenced Works on Psychedelics:

Ralph Metzner

Higher Wisdom

Storming Heaven

Acid Dreams

The Harvard Psychedelic Club

Changing Our Mind

Distilled Spirits

Join the Editors of The Journal of Psychedelic Psychiatry as they discuss Treatment-Resistant Depression with Special Guest and Psychiatrist Dr. Josh Siegel.

Dr. Josh Siegel obtained his BA, MD, and Ph.D. in neuroscience from Washington University in St. Louis, MO. He is currently a PGY2 Psychiatry Resident at Washington University and engaged in research into Treatment-Resistant Depression.

Follow us:

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/

Join the Editors of The Journal of Psychedelic Psychiatry as they discuss Treatment-Resistant Depression with Special Guest and Psychiatrist Dr. Josh Siegel.

Dr. Josh Siegel obtained his BA, MD, and Ph.D. in neuroscience from Washington University in St. Louis, MO. He is currently a PGY2 Psychiatry Resident at Washington University and engaged in research into Treatment-Resistant Depression.

Follow us:

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/

Join the Editors of The Journal of Psychedelic Psychiatry as they discuss Treatment-Resistant Depression with Special Guest and Psychiatrist Dr. Scott Aaronson.

Dr. Scott Aaronson obtained his M.D. from Harvard University in 1981. He is currently an Associate Professor at The University of Maryland School of Medicine, a Distinguished Life Fellow of the American Psychiatric Association, a Fellow of The American College of Psychiatrists. He serves on the board of the American Society of Clinical Psychopharmacology and the board of the Clinical TMS Society. He currently is the Director of Clinical Research for The Retreat at Sheppard Pratt.

Referenced Articles on Treatment-Resistant Depression:

https://www.ncbi.nlm.nih.gov/pubmed/30974339

https://journals.sagepub.com/doi/abs/10.1177/0004867418808585?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=anpa

Follow us:

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/

Join the Editors of The Journal of Psychedelic Psychiatry as they discuss Treatment-Resistant Depression with Special Guest and Psychiatrist Dr. Scott Aaronson.

Dr. Scott Aaronson obtained his M.D. from Harvard University in 1981. He is currently an Associate Professor at The University of Maryland School of Medicine, a Distinguished Life Fellow of the American Psychiatric Association, a Fellow of The American College of Psychiatrists. He serves on the board of the American Society of Clinical Psychopharmacology and the board of the Clinical TMS Society. He currently is the Director of Clinical Research for The Retreat at Sheppard Pratt.

Referenced Articles on Treatment-Resistant Depression:

https://www.ncbi.nlm.nih.gov/pubmed/30974339

https://journals.sagepub.com/doi/abs/10.1177/0004867418808585?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=anpa

Follow us:

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/

Join the Editors of The Journal of Psychedelic Psychiatry as they discuss Treatment-Resistant Depression with Special Guest and Psychiatrist Dr. Alan Schatzberg.

Dr. Alan Schatzberg obtained his M.D. from NYU School of Medicine in 1968 and completed his Residency in Psychiatry in 1972 at The Massachusetts Mental Health Center. He has previously served as the 136thPresident of the American Psychiatric Association and was the Chair of Psychiatry Department at Stanford University from 1991-2010. He currently serves as a Professor of Psychiatry and Behavioral Sciences at Stanford University and is the Director of the Stanford Mood Disorders Center

Referenced Articles on Depression and Psychedelics:

Some Comments on Psychedelic Research: https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2020.20030272

A Word to the Wise about Ketamine: https://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2014.13101434?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

Follow us:

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/

Join the Editors of The Journal of Psychedelic Psychiatry as they discuss Treatment-Resistant Depression with Special Guest and Psychiatrist Dr. Alan Schatzberg.

Dr. Alan Schatzberg obtained his M.D. from NYU School of Medicine in 1968 and completed his Residency in Psychiatry in 1972 at The Massachusetts Mental Health Center. He has previously served as the 136thPresident of the American Psychiatric Association and was the Chair of Psychiatry Department at Stanford University from 1991-2010. He currently serves as a Professor of Psychiatry and Behavioral Sciences at Stanford University and is the Director of the Stanford Mood Disorders Center

Referenced Articles on Depression and Psychedelics:

Some Comments on Psychedelic Research: https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2020.20030272

A Word to the Wise about Ketamine: https://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2014.13101434?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

Follow us:

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/

Join Editor-in-Chief Dr. Tyler Kjorvestad and Deputy Editor Dr. Joe Pullara of The Journal of Psychedelic Psychiatry as they discuss Dr. Pullara's article Positive Response to Ketamine Administration in Treatment-Resistant Psychosis: A Case Report and Dr. Kjorvestad's accompanying editorial Selective Use of Ketamine in Patients with Psychotic Disorders both of which can be found in the latest issue of the journal online. 

Follow us:

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/

Join Editor-in-Chief Dr. Tyler Kjorvestad and Deputy Editor Dr. Joe Pullara of The Journal of Psychedelic Psychiatry as they discuss Dr. Pullara's article Positive Response to Ketamine Administration in Treatment-Resistant Psychosis: A Case Report and Dr. Kjorvestad's accompanying editorial Selective Use of Ketamine in Patients with Psychotic Disorders both of which can be found in the latest issue of the journal online. 

Follow us:

Website: https://www.journalofpsychedelicpsychiatry.org/

Twitter: https://twitter.com/psychedelic_org

Facebook: https://www.facebook.com/JournalofPsychedelicPsychiatry/

Instagram: https://www.instagram.com/journalpsychedelicpsychiatry/